We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
N.J. Enacts Biosimilars Substitution Law
Federal Court Imposes TRO on Dr. Reddy’s Generic Nexium
Amgen’s ABP501 Biosimilar Meets Primary Endpoint
Astellas to Acquire Ocata Therapeutics for $379 Million